Short seller Andrew Left sent Express Scripts shares reeling Thursday afternoon by invoking the wrath of President-elect Donald Trump.

After arresting a series of lower-level workers, the feds on Thursday hauled in former CEO Michael Babich and a group of other execs.

Perrigo’s Omega unit has lagged since the Dublin drugmaker picked it up for $4.5 billion last March. Now, under activist pressure, the company is doing…

The gist of a new report predicting pharma's key numbers for 2017? Big changes in biotech and pharma of late—and pitfalls ahead—but the usual giants still…

Endo’s new CEO is making his presence felt. He's engineering a move away from Endo's once-core pain franchise, cutting 375 sales reps and staffers in…

The Trump administration is considering a far-outside-the-box candidate to lead the FDA in tech capitalist Jim O’Neill, Bloomberg reports.

Any drugmakers still thinking they got off easy when Donald Trump won the U.S. presidential election may want to think again.

When Eli Lilly set aside its Alzheimer’s prospect solanezumab, it also put a set of sales jobs on the chopping block.

Pharma